# Evaluation of Pre-Exposure Prophylaxis (PrEP) in Pregnant and Breastfeeding Women

> **NCT03902418** · — · COMPLETED · sponsor: **University of California, Los Angeles** · enrollment: 1195 (actual)

## Conditions studied

- HIV-I Infection

## Interventions

- **DRUG:** emtricitabine/tenofovir

## Key facts

- **NCT ID:** NCT03902418
- **Lead sponsor:** University of California, Los Angeles
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-01
- **Primary completion:** 2024-06-30
- **Final completion:** 2024-09-30
- **Target enrollment:** 1195 (ACTUAL)
- **Last updated:** 2024-10-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03902418

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03902418, "Evaluation of Pre-Exposure Prophylaxis (PrEP) in Pregnant and Breastfeeding Women". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03902418. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*